On The Pen: The Weekly Dose 3/5/24
Episode description
This week Dave covers the latest in the Change Healthcare Hack, some interesting pubmed tirzepatide data , and Oprah’s exit from the Weight Watchers board of directors.
Become a YouTube Community Member By Clicking Here:
https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
On The Pen Live Show (All Episodes In Order):
https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM
For Those Facing GLP-1 Access Issues:
Https://www.FlexFinance.Care
Tell them “Dave sent you” 😉
Zepbound FB Group:
https://www.facebook.com/share/oxMJXxuLTwczPpWq/?mibextid=K35XfP
SHOW LINKS
Change Healthcare Ransom Paid:
https://www.wired.com/story/alphv-change-healthcare-ransomware-payment/
Pubmed Asians vs. Non-Asians With DM2 Using Tirzepatide
https://pubmed.ncbi.nlm.nih.gov/38402331/
Oprah Leaving WW Board
https://www.thedailybeast.com/oprah-is-leaving-weightwatchers-after-revealing-weight-loss-drug-use
Dr. Michael Albert Interview:
https://youtu.be/nB9CXEsGNDc
The Big Shot Review
https://youtu.be/l-uyFOxqSYk
Our Book Has Been Released!
Decoding GLP-1: A Guide for Friends and Family of Those On The Pen
Buy Here: https://amzn.to/3Dc66d4
DNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP
USE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
Venmo: OnThePen
Ca$h App: ManOnMounjaro
BECOME A MEMBER:
https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
👉 My Amazon Affiliate Store:
https://www.amazon.com/shop/manonthemounjaroonthepen
MORE COMMUNITY!
📺 Watch Our Weekly Live Show: onthepen.tv
🆕 Discord: https://discord.gg/u4Ea8qqP
🤝 Visit Our Sponsor!
GLP-1 Ro Body Plan: https://www.ro.co/otp
Report The Shortage: https://www.ro.co/supply-tracker
Does your insurance cover GLPs? https://www.ro.com/checker
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and...